Previous 10 | Next 10 |
home / stock / ogi / ogi articles
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) reported on Tuesday its fourth quarter financial results for the three months ended Sept. 30., reve...
With a nearly 50% share in infused pre-rolls, which constitute 70% of its sales, Decibel Cannabis Co. Inc. (TSXV: DB) (OTC: DBCCF) is well-pos...
Zuanic & Associates has initiated coverage on Village Farms International (NASDAQ: VFF), assigning an "Overweight" rating. What are t...
German lawmakers are expecting a recently revised version of the marijuana legalization measure to bring about the long-awaited policy change in th...
The landscape of cannabis stocks is undergoing a significant shift, with recent weeks marking a robust uptick in market performance. This surge is ...
Constellation Brands, Inc. (NYSE: STZ) announced last week the expiration of all its warrants to acquire common shares of Canadian cannabis produce...
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock b...
Organigram Holdings Inc. (NASDAQ: OGI) shares are trading higher Monday after the company announced a C$124.6 million investment from British Ameri...
Canadian cannabis company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced on Monday a CA$124.6 million ($91.2 million) follow-on strate...
News, Short Squeeze, Breakout and More Instantly...
Organigram Holdings Inc. Company Name:
OGI Stock Symbol:
NYSE Market:
Organigram Holdings Inc. Website:
Second “Jupiter” investment strengthens Organigram’s European access, including to the high-growth market of Germany Highlights: Concurrent to the investment, Organigram and Sanity Group have entered into a new supply agreement to include significantly higher ...
Over a three-year period, Organigram expects to supply 1,700 kilograms of high-quality medical cannabis flower to Avida Medical, with 500 kilograms expected to be delivered in the first year of the agreement. Avida Medical to become Organigram’s second international medical cannabis cu...